Analysts’ Weekly Ratings Updates for Blue Owl Capital (OWL)

Several analysts have recently updated their ratings and price targets for Blue Owl Capital (NYSE: OWL):

• 2/6/2026 – Blue Owl Capital was given a new $14.00 price target on by analysts at Evercore Inc.
• 2/6/2026 – Blue Owl Capital had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $16.25 to $14.00. They now have a “neutral” rating on the stock.
• 2/6/2026 – Blue Owl Capital had its price target lowered by analysts at Piper Sandler from $21.00 to $15.00. They now have an “overweight” rating on the stock.
• 2/6/2026 – Blue Owl Capital had its price target lowered by analysts at Barclays PLC from $18.00 to $15.00. They now have an “overweight” rating on the stock.
• 2/6/2026 – Blue Owl Capital had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $27.00 to $24.00. They now have an “outperform” rating on the stock.
• 1/27/2026 – Blue Owl Capital had its “outperform” rating reaffirmed by analysts at Citigroup Inc..
• 1/27/2026 – Blue Owl Capital was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating.
• 1/22/2026 – Blue Owl Capital had its price target lowered by analysts at Evercore Inc from $19.00 to $17.00. They now have an “outperform” rating on the stock.
• 1/21/2026 – Blue Owl Capital had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 1/20/2026 – Blue Owl Capital had its “outperform” rating reaffirmed by analysts at Oppenheimer Holdings, Inc.. They now have a $27.00 price target on the stock.
• 1/14/2026 – Blue Owl Capital had its “buy” rating reaffirmed by analysts at TD Cowen.
• 1/14/2026 – Blue Owl Capital had its price target lowered by analysts at TD Cowen from $26.00 to $24.00. They now have a “buy” rating on the stock.
• 1/13/2026 – Blue Owl Capital had its price target lowered by analysts at UBS Group AG from $18.00 to $16.50. They now have a “neutral” rating on the stock.
• 1/9/2026 – Blue Owl Capital had its price target lowered by analysts at Barclays PLC from $19.00 to $18.00. They now have an “overweight” rating on the stock.
• 1/7/2026 – Blue Owl Capital was given a new $20.00 price target on by analysts at Wolfe Research.
• 1/6/2026 – Blue Owl Capital had its “neutral” rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $16.25 price target on the stock.

Blue Owl Capital Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 20th will be given a $0.225 dividend. The ex-dividend date is Friday, February 20th. This represents a $0.90 annualized dividend and a yield of 7.4%. Blue Owl Capital’s dividend payout ratio (DPR) is currently 900.00%.

Insider Buying and Selling at Blue Owl Capital

In other news, CFO Alan Kirshenbaum bought 33,670 shares of the stock in a transaction dated Monday, December 1st. The stock was bought at an average price of $14.87 per share, for a total transaction of $500,672.90. Following the completion of the acquisition, the chief financial officer directly owned 33,670 shares in the company, valued at approximately $500,672.90. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Marc S. Lipschultz purchased 69,663 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The shares were purchased at an average cost of $15.06 per share, for a total transaction of $1,049,124.78. Following the completion of the transaction, the chief executive officer directly owned 79,000 shares of the company’s stock, valued at $1,189,740. This represents a 746.10% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought a total of 395,670 shares of company stock worth $5,952,393 over the last ninety days. Insiders own 27.44% of the company’s stock.

Blue Owl Capital is a global alternative asset manager that focuses on private credit, direct lending and equity-related strategies for institutional investors. Headquartered in New York, the firm develops and manages a range of private markets products designed to provide capital solutions to middle-market and larger corporate borrowers, as well as liquidity and partnership arrangements with private equity firms and other alternative managers.

Its core activities include direct lending and credit strategies that provide senior, unitranche and other structured loan products to companies across industries.